Impact of chemotherapy-induced ovarian failure (CIOF) on disease-free survival (DFS) and overall survival (OS) in young women with early breast cancer (EBC)

Furlanetto J, Nekljudova V, Schneeweiss A, Thode C, Denkert C, Untch M, Bassy M, Karn T, Fasching P, Stickeler E, Schem C, Marme F, Grischke EM, Van Mackelenbergh M, Strik D, Schmatloch S, Mueller V, Loibl S (2019)


Publication Type: Conference contribution

Publication year: 2019

Journal

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Pages Range: 57-+

Conference Proceedings Title: ANNALS OF ONCOLOGY

Event location: Barcelona ES

DOI: 10.1093/annonc/mdz240.006

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Furlanetto, J., Nekljudova, V., Schneeweiss, A., Thode, C., Denkert, C., Untch, M.,... Loibl, S. (2019). Impact of chemotherapy-induced ovarian failure (CIOF) on disease-free survival (DFS) and overall survival (OS) in young women with early breast cancer (EBC). In ANNALS OF ONCOLOGY (pp. 57-+). Barcelona, ES: OXFORD: OXFORD UNIV PRESS.

MLA:

Furlanetto, J., et al. "Impact of chemotherapy-induced ovarian failure (CIOF) on disease-free survival (DFS) and overall survival (OS) in young women with early breast cancer (EBC)." Proceedings of the 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona OXFORD: OXFORD UNIV PRESS, 2019. 57-+.

BibTeX: Download